logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-21. Gender ratio by primary drug — ratio of males to females among new and all clients entering outpatient and inpatient treatment in 2006 [see all tables in this series...]

Part (iv) Ratio of males to females among all clients entering inpatient treatment

CountryOpioidsCocaineStimulantsHypnotics and sedativesHallucinogensVolatile substancesCannabisOther drugsBase (known status)
Bulgaria(1)6.1525
Czech Republic2.21.60.82.04.22.41.01843
Denmark(2)3.23.85.04.04.114.0341
Germany(3)4.28.85.10.62.07.33.16912
Ireland(4)2.86.312.52.52.06.30.0952
Greece(5)5.65.88.04.64.01.31855
France(6)4.27.52.51.95.02.04.113.5390
Cyprus(7)4.28.50.03.0123
Latvia2.93.01.57.06.0626
Luxembourg(8)2.62.3117
Hungary(9)3.24.31.10.55.35.24.81.74967
Austria(10)2.73.23.43.77.21181
Slovakia3.44.00.55.64.5528
Finland(11)2.02.11.81.54.52.0986
Sweden2.67.51.91.62.06.43.12818
United Kingdom(12)2.52.31.71.62.01.51.23346
Turkey16.410.88.84.447.831.56.02796
Total3.64.42.00.75.411.47.22.92.7
Total base14142147735674312775353933226330306

Notes:

 (1) No female cases for cocaine and volatile substances; no cases for hallucinogens and other drugs. 

 (2) No cases for hallucinogens and volatile substances. 

 (3) No female cases for cannabis. 

 (4) No female cases for hallucinogens and other drugs; no cases for Volatile substances. 

 (5) No female cases for stimulants and other drugs; no cases for hallucinogens and volatile substances. 

 (6) No male cases for hypnotics; no female cases for cannabis and cocaine; no cases for hallucinogens, stimulants, volatile substances and other drugs. 

 (7) No cases for hallucinogens, hypnotics, volatile substances and other drugs. 

 (8) No cases for hallucinogens. 

 (9) No female cases for hallucinogens. 

 (10) No female cases for cocaine, hallucinogens and other drugs. 

 (11) No female cases for hallucinogens. 

 (12) No cases for hallucinogens. 

 See also 'General notes for interpreting data’ on the Explanatory notes and help page

Sources:

 Reitox national reports 2007 — TDI — inpatient treatment centres. 

(see the help page for information about formats etc.)

Page last updated: Monday, 14 July 2008